お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は犬の幹細胞治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは犬の幹細胞治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の犬の幹細胞治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは犬の幹細胞治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に犬の幹細胞治療市場を分類しています。本研究に含まれる主な企業は：VETSTEM BIOPHARMA、Cell Therapy Sciences、Regeneus、Aratana Therapeutics、Medivet Biologics、Okyanos、Vetbiologics、VetMatrix、Magellan Stem Cells、ANIMAL CELL THERAPIES、Stemcellvet

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Allogeneic Stem Cells
    Autologous Stem cells

用途別の市場セグメント：
    Veterinary Hospitals
    Veterinary Clinics
    Veterinary Research Institutes

本レポートの詳細内容
世界の犬の幹細胞治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、犬の幹細胞治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の犬の幹細胞治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の犬の幹細胞治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、犬の幹細胞治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

犬の幹細胞治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：犬の幹細胞治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：犬の幹細胞治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章犬の幹細胞治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：犬の幹細胞治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：犬の幹細胞治療の主要企業の概要を提供し、製品の説明と仕様、犬の幹細胞治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Market Analysis and Insights: Global Canine Stem Cell Therapy Market
The global Canine Stem Cell Therapy market is projected to grow from US$ 64 million in 2024 to US$ 79 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
Report Covers:
This report presents an overview of global market for Canine Stem Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Canine Stem Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Canine Stem Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Canine Stem Cell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Canine Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Canine Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix and Magellan Stem Cells, etc.

Market Segmentation
By Company
    VETSTEM BIOPHARMA
    Cell Therapy Sciences
    Regeneus
    Aratana Therapeutics
    Medivet Biologics
    Okyanos
    Vetbiologics
    VetMatrix
    Magellan Stem Cells
    ANIMAL CELL THERAPIES
    Stemcellvet

Segment by Type
    Allogeneic Stem Cells
    Autologous Stem cells

Segment by Application
    Veterinary Hospitals
    Veterinary Clinics
    Veterinary Research Institutes

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Canine Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Stem Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Canine Stem Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Canine Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Allogeneic Stem Cells
    Table 3. Key Players of Autologous Stem cells
    Table 4. Global Canine Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Canine Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Canine Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Canine Stem Cell Therapy Market Share by Region (2019-2024)
    Table 8. Global Canine Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Canine Stem Cell Therapy Market Share by Region (2025-2030)
    Table 10. Canine Stem Cell Therapy Market Trends
    Table 11. Canine Stem Cell Therapy Market Drivers
    Table 12. Canine Stem Cell Therapy Market Challenges
    Table 13. Canine Stem Cell Therapy Market Restraints
    Table 14. Global Canine Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Canine Stem Cell Therapy Revenue Share by Players (2019-2024)
    Table 16. Global Top Canine Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2023)
    Table 17. Global Canine Stem Cell Therapy Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Canine Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Canine Stem Cell Therapy, Headquarters and Area Served
    Table 20. Global Key Players of Canine Stem Cell Therapy, Product and Application
    Table 21. Global Key Players of Canine Stem Cell Therapy, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Canine Stem Cell Therapy Revenue Market Share by Type (2019-2024)
    Table 25. Global Canine Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Canine Stem Cell Therapy Revenue Market Share by Type (2025-2030)
    Table 27. Global Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Canine Stem Cell Therapy Revenue Share by Application (2019-2024)
    Table 29. Global Canine Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Canine Stem Cell Therapy Revenue Share by Application (2025-2030)
    Table 31. North America Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Canine Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Canine Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Canine Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Canine Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Canine Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Canine Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Canine Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Canine Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Canine Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Canine Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Canine Stem Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Canine Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Canine Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Canine Stem Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 63. VETSTEM BIOPHARMA Company Details
    Table 64. VETSTEM BIOPHARMA Business Overview
    Table 65. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product
    Table 66. VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 67. VETSTEM BIOPHARMA Recent Developments
    Table 68. Cell Therapy Sciences Company Details
    Table 69. Cell Therapy Sciences Business Overview
    Table 70. Cell Therapy Sciences Canine Stem Cell Therapy Product
    Table 71. Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 72. Cell Therapy Sciences Recent Developments
    Table 73. Regeneus Company Details
    Table 74. Regeneus Business Overview
    Table 75. Regeneus Canine Stem Cell Therapy Product
    Table 76. Regeneus Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 77. Regeneus Recent Developments
    Table 78. Aratana Therapeutics Company Details
    Table 79. Aratana Therapeutics Business Overview
    Table 80. Aratana Therapeutics Canine Stem Cell Therapy Product
    Table 81. Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 82. Aratana Therapeutics Recent Developments
    Table 83. Medivet Biologics Company Details
    Table 84. Medivet Biologics Business Overview
    Table 85. Medivet Biologics Canine Stem Cell Therapy Product
    Table 86. Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 87. Medivet Biologics Recent Developments
    Table 88. Okyanos Company Details
    Table 89. Okyanos Business Overview
    Table 90. Okyanos Canine Stem Cell Therapy Product
    Table 91. Okyanos Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 92. Okyanos Recent Developments
    Table 93. Vetbiologics Company Details
    Table 94. Vetbiologics Business Overview
    Table 95. Vetbiologics Canine Stem Cell Therapy Product
    Table 96. Vetbiologics Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 97. Vetbiologics Recent Developments
    Table 98. VetMatrix Company Details
    Table 99. VetMatrix Business Overview
    Table 100. VetMatrix Canine Stem Cell Therapy Product
    Table 101. VetMatrix Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 102. VetMatrix Recent Developments
    Table 103. Magellan Stem Cells Company Details
    Table 104. Magellan Stem Cells Business Overview
    Table 105. Magellan Stem Cells Canine Stem Cell Therapy Product
    Table 106. Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 107. Magellan Stem Cells Recent Developments
    Table 108. ANIMAL CELL THERAPIES Company Details
    Table 109. ANIMAL CELL THERAPIES Business Overview
    Table 110. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product
    Table 111. ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 112. ANIMAL CELL THERAPIES Recent Developments
    Table 113. Stemcellvet Company Details
    Table 114. Stemcellvet Business Overview
    Table 115. Stemcellvet Canine Stem Cell Therapy Product
    Table 116. Stemcellvet Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
    Table 117. Stemcellvet Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Canine Stem Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Canine Stem Cell Therapy Market Share by Type: 2023 VS 2030
    Figure 3. Allogeneic Stem Cells Features
    Figure 4. Autologous Stem cells Features
    Figure 5. Global Canine Stem Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Canine Stem Cell Therapy Market Share by Application: 2023 VS 2030
    Figure 7. Veterinary Hospitals Case Studies
    Figure 8. Veterinary Clinics Case Studies
    Figure 9. Veterinary Research Institutes Case Studies
    Figure 10. Canine Stem Cell Therapy Report Years Considered
    Figure 11. Global Canine Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Canine Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Canine Stem Cell Therapy Market Share by Region: 2023 VS 2030
    Figure 14. Global Canine Stem Cell Therapy Market Share by Players in 2023
    Figure 15. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2023
    Figure 17. North America Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Canine Stem Cell Therapy Market Share by Type (2019-2030)
    Figure 19. North America Canine Stem Cell Therapy Market Share by Application (2019-2030)
    Figure 20. North America Canine Stem Cell Therapy Market Share by Country (2019-2030)
    Figure 21. United States Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Canine Stem Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Canine Stem Cell Therapy Market Share by Type (2019-2030)
    Figure 25. Europe Canine Stem Cell Therapy Market Share by Application (2019-2030)
    Figure 26. Europe Canine Stem Cell Therapy Market Share by Country (2019-2030)
    Figure 27. Germany Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Canine Stem Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Canine Stem Cell Therapy Market Share by Type (2019-2030)
    Figure 35. China Canine Stem Cell Therapy Market Share by Application (2019-2030)
    Figure 36. Asia Canine Stem Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Canine Stem Cell Therapy Market Share by Type (2019-2030)
    Figure 38. Asia Canine Stem Cell Therapy Market Share by Application (2019-2030)
    Figure 39. Asia Canine Stem Cell Therapy Market Share by Region (2019-2030)
    Figure 40. Japan Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Canine Stem Cell Therapy Market Share by Country (2019-2030)
    Figure 50. Brazil Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. VETSTEM BIOPHARMA Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 57. Cell Therapy Sciences Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 58. Regeneus Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 59. Aratana Therapeutics Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 60. Medivet Biologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 61. Okyanos Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 62. Vetbiologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 63. VetMatrix Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 64. Magellan Stem Cells Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 65. ANIMAL CELL THERAPIES Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 66. Stemcellvet Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed